Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1426 of 6351
-
New cancer drug targets HER3 in advanced tumors
Disease control Not yet recruitingA Phase 1/2 Study of KHN922 for Injection to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity in Patients with Advanced Solid Tumors
Phase 1/2 • Sponsor: Chengdu Kanghong Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
CBD shown to curb alcohol cravings? phase 2 trial launches.
Disease control Recruiting nowThe goal of this study is to learn how CBD affects drinking in people who drink alcohol regularly. Researchers want to see if CBD can help people drink less and reduce problems related to alcohol use.
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New device aims to seal brain aneurysms without surgery
Disease control Not yet recruitingThe objective of this study is to investgiate the safety and clinical performance of the World Diverter Emoblization Device for the endovascular treatment of wide-neck (neck width ≥ 4 mm or dome-to-neck ratio \<2) or fusiform intracranial aneurysms in the internal carotid artery …
Sponsor: World Medica USA, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New drug shows promise for lupus kidney disease in early trial
Disease control Not yet recruitingThis is a randomized, double-blind, placebo-controlled multicenter clinical study to evaluate the efficacy, safety, and pharmacokinetics of SIM0278 in adult (18-75 years) subjects with active LN suitable for systemic therapy. Approximately 60 subjects with active LN are planned …
Phase 2 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New mindfulness therapy targets PTSD in heart attack survivors
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a new therapy called Acceptance- and Mindfulness-Based Exposure Therapy (AMBET) helps treat post-traumatic stress disorder (PTSD) in people who survived a cardiac arrest. This study will compare AMBET to another psychotherapy treatme…
Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New shot could help lower stubborn high cholesterol
Disease control Not yet recruitingThe purpose of this study is to compare the effectiveness, safety of SYH2053 in participants with primary hypercholesterolemia (non-familial) or mixed dyslipidemia on a background of lipid-lowering therapy. This trial plans to enroll 900 Participants.
Phase 3 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for lymphoma patients: experimental drug TORL-5-700 enters human trials
Disease control Recruiting nowA Phase 1/2 study to evaluate safety, tolerability, and anticancer activity of TORL-5-700 as a monotherapy and in combination in R/R NHL
Phase 1/2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New smart chemo targets tumors, spares healthy tissue
Disease control Recruiting nowThis is a first-in-human (FIH), Phase 1 open-label, multicenter dose escalation study investigating AVA6103 monotherapy administered intravenously in patients with locally advanced (unresectable) or metastatic solid tumors that are likely to be FAP positive. The study consists of…
Phase 1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug cocktail aims to halt sarcoma progression
Disease control Not yet recruitingThe study is expected to include 24 patients with metastatic or surgically unresectable relapsed/refractory soft tissue sarcoma confirmed by histological evidence, who have received at least one line of systemic treatment previously. The efficacy and safety of liposome irinotecan…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New study tests best way to deliver antibiotic combo against superbugs
Disease control Recruiting nowMetallo-β-lactamase-producing carbapenem-resistant Gram-negative bacteria (MBL-CR-GNB), due to their capacity to hydrolyze almost all β-lactam antibiotics, have become a critical global threat in antimicrobial resistance. Current novel β-lactamase inhibitors (e.g., avibactam, rel…
Phase 4 • Sponsor: Jing Zhou • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug duo aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis is a Phase 1/2, open-label, dose escalation and expansion study to assess the safety, pharmacokinetics, and preliminary efficacy of BC3195 in combination with pembrolizumab in participants with locally advanced or metastatic solid tumors.
Phase 1/2 • Sponsor: Biocity Biopharmaceutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Can immune cells revive lung cancer treatment?
Disease control Not yet recruitingThis is a single-arm study designed to evaluate the safety and efficacy of TILs combined with third-generation EGFR-TKIs therapy for patients with EGFR-mutant NSCLC resistant to TKI.
Early phase 1 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Higher voltage nerve zap may ease chronic migraine
Symptom relief Recruiting now* PRF performed on the sphenopalatine ganglion level under ultrasound guidance. * Standard voltage PRF parameters: 45 V, 5 Hz frequency, 5 ms pulse width, 360 seconds duration, electrode temperature ≤42°C. * Supravoltage PRF parameters: Higher voltage than standard (e.g., 60-70 V…
Sponsor: Minia University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Trained volunteers may boost dementia Patients' brain power
Symptom relief Recruiting nowThe goal of this mixed method study is to evaluate whether the volunteer-led Cognitive Stimulation Therapy (CST) under the BrainLive Connect programme is effective for improving cognitive function and quality of life of people living with dementia (PLwD). The main question it ai…
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Poop pills for newborns: could a fecal transplant prevent obesity?
Prevention Recruiting nowThis single-center randomized controlled trial evaluates whether donor-derived fecal microbiota transplantation (FMT) administered within 6 hours after birth can improve gut microbiota development and reduce the risk of immune-mediated and metabolic diseases in infants born by el…
Sponsor: Oulu University Hospital • Aim: Prevention
Last updated Jul 23, 2026 00:00 UTC
-
Head-to-Head: which obesity drug wins for fat loss and heart health?
Disease control Recruiting nowThis randomized, open label, head to head clinical trial directly compares tirzepatide and semaglutide in adults with obesity and metabolic syndrome (N=120, age 20-65, 1:1 randomization). Participants undergo deep phenotyping at baseline, 6 months, and 12 months, including DXA (r…
Sponsor: Tri-Service General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Brain chemical orexin may hold key to preventing post-surgery confusion in elderly
Knowledge-focused By invitation onlyTo explore the relationship between plasma orexin levels during the recovery period of elderly patients undergoing general anesthesia and the occurrence of emergence delirium, and to evaluate its sensitivity and specificity as an objective diagnostic indicator for emergence delir…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Listening to the brainstem: a new window into autism?
Knowledge-focused OngoingThis retrospective study investigates auditory brainstem evoked potentials (BAEPs) in children with autism spectrum disorder (ASD) compared with other neuropsychiatric conditions. The study aims to evaluate differences in BAEP parameters, with particular attention to sex- and age…
Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
New drug aims to shrink polyps in inherited colon cancer condition
Disease control Recruiting nowThis open-label phase II trial tests how well TPST-1495 works in reducing the number of polyps in the small bowel and colon in patients with familial adenomatous polyposis (FAP). FAP is an inherited condition in which numerous polyps (growths that protrude from mucous membranes) …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Does replacing a heart valve clear fluid from the lungs?
Knowledge-focused Recruiting nowThis prospective, single-center observational study aims to evaluate the relationship between changes in aortic valve hemodynamics and pulmonary congestion in patients undergoing elective transfemoral transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic st…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC